Bellevue Life Sciences Acquisit
Q4 2023 13F Holders
Symbol
BLAC
CUSIP
079174108
Type
Equity
Class
COM
Num filings
25
Total reported value, excl. options
$31.2 M
Compare 2023 Q4 to
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q3
2023 Q2
2023 Q1
Manager
Report Date
Value ($000)
Shares
Option Type